COVID-19

Moderna says a study in kids 6 to 11 found two doses of the company's COVID-19 vaccine given 28 days apart produced a strong antibody response.

The program will let neighborhoods apply for "Living Street" status, giving them permission to implement measures to encourage walking, biking and play.

The companies studied a 10 microgram vaccine dose in children 5 to 11, a third of the dose used for adults, to minimize side effects and because it still prompts a strong immune response.

CDC Director Rochelle Walensky also endorsed a mix-and-match approach to boosters that would be flexible for patients and health care providers.

A family in Houston and a plumber in Maryland couldn't afford rent, which pushed them into crowded living quarters. During the COVID-19 pandemic, that common predicament has increased viral spread.

The Food and Drug Administration also gave an OK to boosters that differ from the vaccine originally used to immunize people against COVID-19. A mix-and-match approach could ease the booster rollout.

The White House says the U.S. has enough doses for the country's 28 million kids age 5 to 11 and has laid out a plan to get them inoculated as soon as the vaccine is authorized for the age group.

Founders Seth Green and Eric Heiret had considered putting their business on hold last year. But then the world shut down, and they took that as a sign to keep going.

In her state of the district address Tuesday, Stephanie Elizalde credited the mask mandate, in part, for the low number of COVID cases in Austin schools.

And more than 1 in 3 adults in households with children say they have experienced serious problems meeting both their work and family responsibilities, according to an NPR poll.